NEWS
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Joshua F Zeidner
University of North Carolina Chapel Hill - Chapel Hill / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1461984
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Joshua F Zeidner's MOST POPULAR ARTICLES
1-)
Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacyQ Hu, W Sun, J Wang, H Ruan, X Zhang, Y Ye, S Shen, C Wang, W Lu, ...Nature biomedical engineering 2 (11), 831-840, 20181612018
2-)
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AMLRT Swords, S Coutre, MB Maris, JF Zeidner, JM Foran, J Cruz, HP Erba, ...Blood, The Journal of the American Society of Hematology 131 (13), 1415-1424, 20181582018
3-)
Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapyHA Knaus, S Berglund, H Hackl, AL Blackford, JF Zeidner, ...JCI insight 3 (21), 20181062018
4-)
Clinical activity of alvocidib (flavopiridol) in acute myeloid leukemiaJF Zeidner, JE KarpLeukemia research 39 (12), 1312-1318, 20151292015
5-)
Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+ 3) in newly diagnosed acute myeloid …JF Zeidner, MC Foster, AL Blackford, MR Litzow, LE Morris, SA Strickland, ...haematologica 100 (9), 1172, 20151102015
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept